ライフサイエンスコーパス: neurologic symptom

1 the gut, and it is also related to renal and neurologic symptoms.

2 omyopathy 11 months prior to presentation of neurologic symptoms.

3 luding gastrointestinal, musculoskeletal and neurologic symptoms.

4 orresponding evidence by clinical imaging or neurologic symptoms.

5 o a highly overlapping phenotype without the neurologic symptoms.

6 ical manifestations include hypertension and neurologic symptoms.

7 associated with bone, connective tissue, and neurologic symptoms.

8 R imaging of the brain for the evaluation of neurologic symptoms.

9 h rituximab and who subsequently develop new neurologic symptoms.

10 n of mutant animals and delayed the onset of neurologic symptoms.

11 ied an average of 13 days after the onset of neurologic symptoms.

12 ed in some cases with transient worsening of neurologic symptoms.

13 ppression, elevated liver enzyme levels, and neurologic symptoms.

14 vere xeroderma pigmentosum/Cockayne syndrome neurologic symptoms.

15 , in the other patient, resulted in improved neurologic symptoms.

16 and 67% of patients younger than age 80 had neurologic symptoms.

17 with intellectual disability and progressive neurologic symptoms.

18 infarction, and all had consistent, acquired neurologic symptoms.

19 juni in their stools at the time of onset of neurologic symptoms.

20 tients have shown symptomatic improvement in neurologic symptoms, 1 patient has developed heart failu

21 rmed for gastrointestinal obstruction (34%), neurologic symptoms (23%), pain (12%), dyspnea (9%), jau

22 100% had gastrointestinal symptoms, 34% had neurologic symptoms, 43% had hemorrhagic manifestations,

23 , conjunctivitis, headache, and other severe neurologic symptoms 7 to 24 hours after hemodialysis dre

24 lidocaine to reduce the problem of transient neurologic symptoms after spinal blockade.

25 loads were detected in 42% of patients with neurologic symptoms and 44% of voluntary blood donors.

26 s suggest that the presence of preprocedural neurologic symptoms and a history of CAD are associated

27 tionship usually exists between the onset of neurologic symptoms and an infection or a vaccination.

28 Plaques associated with neurologic symptoms and asymptomatic plaques were compar

29 of immune response associated with distinct neurologic symptoms and cancers.

30 ic regression to evaluate the association of neurologic symptoms and examination findings with FM sta

31 The patient denies any neurologic symptoms and has no significant findings on n

32 with vision loss or diplopia accompanied by neurologic symptoms and in the absence of an intraocular

33 healthy subjects and 33 of 37 patients with neurologic symptoms and normal CSF and imaging studies c

34 tion carries a significant risk of transient neurologic symptoms and should be avoided.

35 f cyclovertical muscles, in association with neurologic symptoms and signs and with posterior fossa l

36 We report on 7 female patients with neurologic symptoms and signs including bilateral thalam

37 ith severe and persistent headache and other neurologic symptoms and signs should be considered for n

38 mboembolic events, seizures, fluctuations in neurologic symptoms, and adverse effects from corticoste

39 his hands and feet, with associated fevers, neurologic symptoms, and arthritis, who required hospita

40 ytopenia, microangiopathic hemolytic anemia, neurologic symptoms, and renal insufficiency, making the

41 , stage of disease, duration and severity of neurologic symptoms, and therapeutic intervention.

42 Neurologic symptoms are more severe and more likely to b

43 n abnormal human HD gene (line R6/2) develop neurologic symptoms at 9-11 weeks of age through an unkn

44 Forty-three (52%) of the patients had neurologic symptoms at diagnosis.

45 The efavirenz group experienced more neurologic symptoms at week 1 (P < 0.001) but not at wee

46 g and occurs in two distinct forms, an acute neurologic symptom complex that occurs within hours or d

47 s, in these experiments, the distribution of neurologic symptoms depends on the expression level and

48 Quantified HCHO was associated with neurologic symptoms (difficulty concentrating POR 1.47;

49 led trial, efavirenz use was associated with neurologic symptoms distinct from depression and anxiety

50 However, neurologic symptoms do not manifest until late stages of

51 ay provide an anatomic basis for some of the neurologic symptoms found in FIV-infected cats and HIV-i

52 in the treatment of CNS metastases; however, neurologic symptoms frequently are not fully reversible,

53 performed on 54853 patients with unexplained neurologic symptoms identified 1992 patients (4%) who we

54 available 1 week prior to the development of neurologic symptoms in 11 patients.

55 The presence of neurologic symptoms in aceruloplasminemia is unique amon

56 ing plerixafor had an increased incidence of neurologic symptoms in association with CNS infiltration

57 er, LPL(-/-) mice developed much less severe neurologic symptoms in experimental autoimmune encephalo

58 opment is consistent with the development of neurologic symptoms in med and jolting mice, which have

59 ination is largely responsible for sustained neurologic symptoms in multiple sclerosis (MS).

60 Increased focus on neurologic symptoms in patients with rosacea may be warr

61 eloped into adulthood, did not develop overt neurologic symptoms in the first year of life, and had n

62 Some neurologic symptoms in the form of seizures and nystagmu

63 ients), new or worsening back pain (in 50%), neurologic symptoms (in 48%), nausea (in 39%), and stiff

64 Other neurologic symptoms included eye movement abnormalities

65 Preprocedural neurologic symptoms included transient ischemic attack,

66 Neurologic symptoms lasting at least 3 months were asses

67 e finding of immunity to Ma proteins is that neurologic symptoms may improve or resolve.

68 studies are best reserved for children with neurologic symptoms, neuropsychometric deficits, or elev

69 Neurologic symptoms occurred in 38% of reports.

70 After logistic regression, the neurologic symptoms (odds ratio: 48.7, 95% confidence in

71 concentrations but do not display the usual neurologic symptoms of hyperammonemia.

72 being applied to the study of the transient neurologic symptoms of the aura, as well as the painful

73 Median age at neurologic symptom onset was 42 years (range, 21-73 year

74 He denied neurologic symptoms or worsening of pain while lying dow

75 re referred for feeding difficulties, subtle neurologic symptoms, or delayed psychomotor development

76 ar cardiac phenotype but a greater burden of neurologic symptoms (pain, numbness, tingling, and walki

77 siologic processes leading to development of neurologic symptoms, particularly in patients with syste

78 anthrax include the presence of nonheadache neurologic symptoms (positive likelihood ratio cannot be

79 Immediate neurologic symptoms postinjury were used to identify mil

80 None of the patients had ever experienced neurologic symptoms prior to the episode of optic neurit

81 l brain lesions in patients with unexplained neurologic symptoms represents a challenge.

82 yperactivity are more susceptible to develop neurologic symptoms such as mental retardation and autis

83 The FM group had more neurologic symptoms than did the controls, with moderate

84 milarly, the FM group had significantly more neurologic symptoms than the control group in 27 of 29 c

85 ist therapy is supported by the worsening of neurologic symptoms that occurred in our index patient f

86 Among older patients and those with neurologic symptoms, the syndrome often progresses to re

87 7% of HIV-infected patients presenting with neurologic symptoms; the diagnosis of VZV-related CNS di

88 ght patients with preeclampsia-eclampsia and neurologic symptoms underwent magnetic resonance (MR) im

89 d cases demonstrate partial reversibility of neurologic symptoms upon restoration of CNS creatine lev

90 Median age at onset of neurologic symptoms was 58 (range, 27-83) years, and 87

91 lings (P=0.004), and the respective rates of neurologic symptoms were 4.0% and 9.4% (P=0.01).

92 The incidence of HAM/TSP and new signs and neurologic symptoms were computed in a group of patients

93 Changes in efavirenz-associated neurologic symptoms were correlated to efavirenz plasma

94 Preprocedural neurologic symptoms were present in 32%.

95 4 consecutive HIV-infected patients with new neurologic symptoms were tested for VZV DNA by a polymer

96 Neutropenia and neurologic symptoms were the most frequent reasons for e

97 s with newly diagnosed SLE, who had no focal neurologic symptoms, were studied.

98 model was instituted on animal's display of neurologic symptoms, which usually led to rapid demise.

99 Resolution of neurologic symptoms with initial steroid therapy, relaps